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I am always proud
to announce the
exciting new work
our faculty and
staff are doing 
to advance and
define the future
of research, 
education, and
clinical care.
Highlights of this
issue include: Dr. Whellan and his team on
leading the region in clinical research and
related outcomes; Dr. Most on his German
roots and directing the Laboratory for
Cardiac Stem Cell and Gene Therapy; Dr.
Fink on the Hospitalist Program; and Dr.
Jaffe on the Sleep Disorders Center and its
new state-of-the-art facility here on campus.
I also thank the many generous 
organizations and individuals (listed on
pages 5–6), who support our work through
gifts to the Department. Without them we
would be facing an even greater struggle
for disappearing federal grants and
research dollars. We treasure them as 
members of the Jefferson family and 
welcome them to visit us regularly to 
see first-hand all of our latest initiatives.  
As the largest and most diverse department
within the University, we have many more
exciting initiatives and updates to share
than we can contain in these few pages. 
For this reason we are now including more 
in-depth articles on the department website
(www.jefferson.edu/medicine). We look 
forward to sharing all of the future 
developments, which keep us very hard 
at work. 
Arthur M. Feldman, MD, PhD
Magee Professor of Medicine and 
Chairman of the Department
From the
Chairman
Clinical research within an academic
institution like Jefferson is a complex and
unique endeavor. Beyond the painstaking
procedures, analysis, and publishing is 
the leadership and vision, which is where
Assistant Professor David Whellan, MD,
MHS, comes in. Board-certified in both 
internal medicine and cardiology, he is also
Director of Clinical Outcomes Research for
the Department of Medicine and Director
of Clinical Research for the Jefferson 
Heart Institute (JHI). 
Dr. Whellan has extensive experience in 
clinical trial design and outcomes research,
having worked with the National Heart,
Lung, and Blood Institute, as well as 
industry sponsors, to develop and complete
clinical studies. He also sees patients at 
the JHI Advanced Heart Failure and 
Cardiac Transplant Center and was recently
named an Associate Editor of the
American Heart Journal. 
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Clinical Outcomes Research Team 
1st row bottom (left to right): Alicia Ervin, RN;
David Whellan, MD, MHS; Colleen Flanagan,
RN. 2nd row: Christine Powel, RN; William
Nicholl; Ginger Mooney; Elizabeth Grace, RN.
3rd row: Jennifer Contipodero; Barbara
Gallagher; Suzanne Adams, RN, MPH; Deborah
Moretti; Conchita Ballard; Megan Mortimer
A Comprehensive Pursuit:
The Jefferson Clinical
Research Program 
Continued on page 7
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Patrick Most, MD, PhD, is an Assistant
Professor and directs the Center for
Translational Medicine’s Laboratory for
Cardiac Stem Cell and Gene Therapy. He
recently sat down with Translations editors
to shed some light on his training in
Germany, his research, and his aspirations
as a clinician.
You run a lab in Heidelberg as
well as here, yes?
Yes — I go back and forth between the
two, since both labs have their unique
advantages, resulting in some synergistic
effects. Two of my former doctoral 
students, Mirko Völkers and Sven Pleger,
now both working as physicians at the
University of Heidelberg, help me run the
lab there. And for now, my wife’s career
keeps her in Germany, so I get back as
often as my work here allows me. 
Where did you grow up and do
your training?
I was born just outside Frankfurt in a small
town, but I studied medicine in Heidelberg.
I then started my doctoral thesis in the lab
of Dr. Katus, at that time the senior staff
of the cardiology division at the University
of Heidelberg. I finished in 1996 and then
went with him to the University of Lübeck,
where he became head of the medical
department. This coincided with the start
of my clinical education as a physician. 
How did you come to the Center
for Translational Medicine at
Jefferson?
A friend from Hamburg put me in touch
with Dr. Walter Koch [now Director of 
the Jefferson Center for Translational
Medicine], who was then at Duke, doing
research in gene transfer. We were 
interested in gene transfer strategies 
to intensify our research, and this new 
technique was almost at its height. So
starting in 2001, I joined Dr. Koch’s lab 
for the first of several successful projects.
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In 2003, I joined his new lab at Jefferson
for my post-doc and we had two major
breakthroughs. It was exciting to join the
Center in its early days and see it grow 
so successfully. In 2004, I returned to
Germany to complete my clinical training,
but Dr. Koch made me an attractive offer
to return afterwards. 
What’s the connection between
what you studied then and what
you are researching now?
The protein we are currently working on
was already the subject of my doctoral
thesis 11 years ago. Looking back, it’s 
fascinating that we started almost from
scratch — literally knowing nothing 11
years ago — and now are knocking on 
the door of a clinical breakthrough. We
now know that this cardiac-specific protein
(S100A1)  has the ability to enhance 
cardiac function without any negative 
consequences. We discovered that failing
hearts lose most of their S100A1 protein,
which causes them to fail more rapidly.
And now that we understand the molecular
mechanism, we are pushing forward to
develop this as therapy to support the failing
heart and restore its contractile function. 
How does your work benefit from
training both as a clinician and
as a basic researcher?
The two have definitely guided my research
interests. My clinical background puts me
in the unique position to combine medical
needs with hypothesis-driven research to
find new ways to cure our patients. The
challenge of heart failure — with a mortality
rate of 50%, which rivals cancer mortality — 
is that there are currently no therapies that
target defective cardiac function, only
ways to avoid or suppress the maladaptive
compensatory reactions of the body if a
patient has already sustained damage. So 
I sought a research path that was going to
break the vicious cycle and would actually
enhance cardiac function and improve 
survival by directly targeting the mechanisms
that cause hearts to fail. 
What is your hope that the 
outcome of this research will 
offer patients?
I am currently following a new lead showing
that one tiny end of S100A1 protein can
be chemically synthesized and penetrate
cardiomyocytes (heart cells) and then
improve their function, protect from
arrhythmias, and even prevent death of
those cells. With this simpler approach, 
we are advancing to animal models. 
I’m hoping that this could constitute an
alternate means to the same end, but
could be administered through an IV. My
hope is that I will meet the first patient 
to receive these therapies I have been
developing over the past decade. ■
Cardiology
Assistant Professor Patrick Most, MD, PhD,
directs the Center for Translational Medicine’s
Laboratory for Cardiac Stem Cell and 
Gene Therapy.
Center for Translational Medicine
Patrick Most: 
Knocking on the Door for a Cure
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Continued from page 1
JHI currently has several such projects that
are funded. “We provide the infrastructure,
from development of proposals and budgets
to implementing the study, collecting data,
performing analyses, and writing up the
results,” Dr. Whellan explains. A third 
component is the JHI Cardiovascular
Research Group (JCRG), managed by
Elizabeth Grace, RN, which supports both
industry-sponsored and investigator-initiated
clinical trials by managing regulatory 
documents, enrolling subjects, and managing
research accounts. 
Dr. Whellan also directs the Jefferson Clinical
Trials Group (JCTG), overseen by Deborah
Moretti, RN. This academic research 
organization (ARO) manages large clinical
trials at a number of other academic and
clinical centers throughout the U.S. They
are currently preparing two studies that 
evaluate new therapies for patients with
acute heart failure.
Dr. Whellan’s goal is to integrate as many
University-wide components as possible
and develop clinical research initiatives. For
example, an outcomes research group that
includes Ms. Adams and Scott Silvestry,
MD, Assistant Professor of Cardiothoracic
Surgery, used a database from the University
HealthSystem Consortium — an academic
benchmarking agency in which the
University participates — to evaluate clinical
outcomes in patients undergoing off-pump
coronary bypass surgery and given Plavix
(clopidogrel). They presented results at the
American College of Cardiology Scientific
Meetings in New Orleans this year. A related
investigator-initiated proposal is under review
by sponsors to fund a multi-center trial,
which would include enrollment at Jefferson
Hospital and other JCTG-managed sites. 
“JHI is positioning itself to provide a full
range of clinical research opportunities 
for faculty, fellows, residents and medical
students,” says Whellan. “We are in an
exciting phase of development in supporting
research that we hope will improve the
care and health of our patients.” ■
many people, including physicians, still
view sleep disorders as largely psychologically
based,” he says, so they can frequently
can go unchecked or misdiagnosed. “Our
goal,” says Jaffe, “is to raise awareness 
of talking to patients about sleep during
regular health assessments, since treatments
can have a tremendous positive impact on
people’s overall health.”
In June 2007, the Center opened its new
state-of-the-art facility at 9th and Walnut
Streets on the Jefferson Center City campus.
Patients who require overnight evaluations
and monitoring sleep in one of ten 
bedrooms, which not only are equipped
with the most advanced sleep-monitoring 
technology, but are also hotel standard:
with private baths, flat-screen televisions,
and individual temperature controls. The
Center also offers a kitchen, study and
lounge area, and indoor parking.  
To learn more about sleep disorders and
the Jefferson Sleep Disorders Center visit
us online at www.jeffersonhospital.org/
psychiatry/article11031.html. ■
The Problem of Rest
Continued from page 4
Helping Patients Write New 
Life Stories
Continued from page 3
small intestine — an area of bowel that
could previously be evaluated only by x-ray. 
A specialist in ulcerative colitis and Crohn’s
disease, as well as microscopic colitis, Dr.
Kozuch now leads Jefferson’s IBD Diagnostic
and Treatment Center. She and her 
colleagues from the GI Division as well 
as the departments of Surgery, Radiology,
and Pathology offer a multidisciplinary
approach to treatment and provide 
comprehensive, cutting-edge care for
patients suffering from both of these chronic
conditions. The Center staff also conducts
clinical trials to evaluate new medications.
Dr. Kozuch’s own research interests include
trying to better delineate the factors that
contribute to the established increased risk
of colon cancer in patients with ulcerative
colitis and Crohn’s disease of the colon.
“The more we understand, the more we
can do for people,” she says. “It’s incredibly
exciting to be involved as we make 
discoveries that will ultimately change the
lives of the people we care for every day.”
Assistant Professor Patricia Kozuch, MD, directs the
Irritable Bowel Disease Diagnostic and Treatment
Center at Jefferson.
For more information about the IBD
Center, visit www.jefferson.edu/gi/
institute/centers1.cfm. ■
The first component of the Cardiology
Clinical Research Program is outcomes
research, which creates databases that
enable researchers to do retrospective
analyses. To implement the outcomes
research projects, Dr. Whellan works 
with Suzanne Adams, RN, MPH, Assistant
Director of Clinical Outcomes Research,
and a number of Jefferson investigators 
in the Center for Translational Medicine;
the Center for Research in Medical
Education and Health Care, and the
Biostatistics Division of Pharmacology and
Experimental Therapeutics. “Once the data
is compiled into an analysis dataset,” Dr.
Whellan says, “physicians-in-training can
explore different hypotheses with mentors
and statisticians and experience the entire
research process, from developing a 
protocol and IRB submission to presenting
results at national meetings.” 
The second component involves design
and development of prospective research
projects initiated by Jefferson faculty. 
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Supporting the Future
Continued from previous page
At a gala held October 11, 2007, Thomas
Jefferson University (TJU) and Thomas
Jefferson University Hospital (TJUH) 
honored Anthony J. DiMarino, Jr., MD,
with its Achievement Award in Medicine.
This award goes to “individuals who have
achieved and maintained excellence in 
their profession and who have actively 
contributed to the growth and development
of their field.”
A preeminent consultative gastroenterologist,
Dr. DiMarino joined Jefferson in 1996 as
the William Rorer Professor of Medicine
and Chief of the GI Division. He has been
honored as “Physician of the Year” by the
Delaware Valley Chapter of the Crohn’s &
Colitis Foundation of America, as a “Top
Doc” in Philadelphia Magazine (1991–
2007), and as one of America’s “Best
Doctors” by Castle Connolly Medical, Ltd.
The reception and dinner, held at the
Marriott Hotel Grand Ballroom in Center
City, was co-chaired by Ira Brind, Joanne
and Jack Dorey, Marjorie and Jeffrey
Honickman, Adele and Harold Schaeffer,
and Tonia and Fred Tecce. The event also
recognized Lynne and Harold Honickman
with the Award of Merit.
This is the second time in three years that
a Department of Medicine Division Chief
has been honored by the hospital and 
university in this capacity. Bernard L. Segal,
MD, was similarly recognized in 2005. ■
Anthony J. DiMarino, Jr., MD
Honorary Gala
Celebrates GI Chief
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It was not so many years ago that the
word “hospitalist” would inspire blank
stares, although this model of “hospital
specialists” was developed a decade ago.
The Jefferson Hospitalist program continues
to expand, and the 2007–08 academic
year includes the addition of three new
physicians, two of whom were recently
graduated residents at Jefferson.
“Jefferson picked up early on this model
for care,” says Hospitalist Program Director
James Fink, MD. “But over the past few
years the institution has invested significantly
in the program, to ensure the best possible
care for patients, the most efficient use of
hospital resources, and excellent training
for its medical students and residents.” 
Dr. Fink explains that “before hospitalist
medicine, the attending physicians would
come into the hospital only as needed 
to check on patients and order tests, and
then might not be available to patients or
families until the next day.” But by definition,
hospitalists are on-site specialists focusing
on in-patient care and efficiency — a critical
role given the costs and other realities of
the current health care climate. 
The Hospitalist program assists specifically
with case management issues, from 
coordinating follow-up care to helping
patients handle insurance. The program
also plans to become more involved in
areas like patient safety and improving the
transition of patients into and out of the
hospital. “This is a natural progression,”
says Dr. Fink, “given that we are stationed
in the hospital. We act as advocates for the
patient and, simultaneously, help to advise
the hospital on its procedures and resources.”
The Hospitalist program oversees 
approximately 100 patients every day
through five in-patient services; four of
these are teaching services, on which 
the physicians round for 2-3 hours every 
morning, instructing their residents while
they see patients. Hospitalists are then
available to their patients and resident
teams — throughout the day. 
One advantage of hospitalist medicine, says
Fink, is that physicians can choose from a
range of niches based on their interests. For
example, Jeff Riggio, MD, has leveraged his
interest in technology to focus on how best
to address patients’ needs using the latest
computer and software systems available.
Two others focus especially on case 
management, working closely with social
workers and staff. Some concentrate on
medical consultation either at TJUH or at the
Jefferson Hospital for Neuroscience, where
the hospitalist group co-manages the
patients admitted to the neurosurgery service.
“This is a young and extremely motivated
group,” Dr. Fink says, “and we look forward
to continuing to provide great care to our
patients, excellent teaching to our students
and residents, and expanding our roles as
physicians who are integral to the future
of health care at TJUH.” ■
Internal Medicine
Hospitalist Program: Care Tailored to Being There
Gastroenterology and Hepatology
“I love learning each patient’s unique history,
personally and medically,” says Assistant
Professor Patricia Kozuch, MD. Having
joined the Division of Gastroenterology
and Hepatology (GI) in September 2006,
she focuses on the all-too-common
Inflammatory Bowel Disease (IBD).
“Attending to these nuances,” says Dr.
Kozuch, “helps me to devise treatments
that are more artful and individualized.”
Dr. Kozuch first became interested in 
gastroenterology as a medical student 
at Cornell University. Later, she pursued 
an advanced fellowship in IBD at the
University of Chicago Hospitals with
Stephen Hanauer, MD, who leads an 
internationally recognized IBD referral 
center and team of doctors.
“The study of IBD is truly burgeoning,” 
Helping Patients Write New Life Stories
3
Dr. Kozuch explains. “And a greater 
understanding of disease pathogenesis
translates into the development of new
medical therapies, which provide us with 
a greater range of equipment, technology,
and medication.” She notes that recent
technology such as capsule and double-
balloon endoscopy has significantly
improved physicians’ ability to diagnose
IBD and other diseases that affect the 
Jefferson Hospitalists (left to right): Walter
Kraft, MD; Mary deVry, CRNP; Elizabeth
Teperov, MD;  Donna Williams, MD; 
Gretchen Diemer, MD; James Fink, MD; 
Taki Galanis, MD; Kimberly Covington, CRNP;
Jessica Salt, MD; and James Davis, MD
Continued on page 7
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We humans spend a third of our lives
asleep. We need close to eight hours a 
day to function productively and maintain
good health. “Yet 70 million people a year
have difficulty sleeping and approximately
60 percent suffer from a chronic sleep-
related disorder,” says Fredric Jaffe, DO,
Assistant Director of the Jefferson Sleep
Disorders Center as well as Assistant
Professor of Medicine in the Division of
Pulmonary and Critical Care Medicine.
Since 1978, the Jefferson Sleep Disorders
Center — now a joint initiative of TJUH
and Jefferson University Physicians — has
been working to understand and treat rare
and common sleep disorders, including
sleep apnea syndromes, insomnia and 
narcolepsy, sleep walking and talking, 
head banging, and nightmares.
Jefferson’s program was the first of its kind
in the Delaware Valley. Although more
than 30 centers now exist in the area, the
center continues to distinguish itself by
approaching sleep from a multidisciplinary
and team-based perspective. 
“Every patient presents with unique and
complex medical needs,” says Dr. Jaffe.
“Our job is to provide the best diagnostic
evaluation and appropriate course of 
treatment in collaboration with other 
medical disciplines.” Each patient receives
an objective physical assessment using the
latest technology that examines everything
from neurological and pulmonary conditions
to potential otolaryngological and 
psychiatric causes. 
The Problem of Rest: Jefferson Sleep
Disorders Center
The daily responsibilities of the department’s
chief residents might daunt even the most
hardworking among us. Elected by their
peers, they are responsible for administrative
and educational duties that include planning
a daily morning report, conferences, and
weekly lectures. Additionally, they coordinate
grand rounds, represent the department on
numerous committees, and run the weekly
morbidity and mortality report, in which
residents discuss and learn from mistakes. 
Sharing these responsibilities this year are
the 2007–2008 chief residents: Mary Kate
McCullen, MD; Andrew Rose, MD; and
Joanna Kipnes, MD.
Dr. McCullen, a
Havertown, PA, 
native and graduate 
of Jefferson Medical
College (elected to
honor medical society
Alpha Omega Alpha, or
AOA), plans to specialize
in Endocrinology, with
a focus on diabetes,
“because it can be such a debilitating 
disease if not controlled,” says Dr. McCullen.
In addition to spending time with her 
husband — a Jefferson anesthesiology 
resident — the classical violinist even squeezes
in some hours of practice each week. 
Before graduating
(AOA) from Columbia
University College 
of Physicians and
Surgeons, Dr. Rose
worked as a 
pharmaceutical
researcher. “It’s much
more satisfying to work
with patients,” he says.
Next year, Dr. Rose will
do a fellowship in cardiology and critical
care. He volunteers as editor of the
Jefferson Medical Forum, resident advisor
for the hospital’s Rapid Response Team,
and executive member of the hospital’s
curriculum committee. He’s also raised
more than $40,000, through walks and
marathons, for amyotrophic lateral sclerosis
(ALS) research in honor of his brother, who
was recently diagnosed with ALS. This 
fall Dr. Rose and his wife, a chief resident
in pediatrics at Children’s Hospital of
Philadelphia, welcomed their first child.
Internal Chief Medicine
resident Dr. Kipnes
has an MS in clinical
pharmacology from
Thomas Jefferson
University and an MD
(AOA) from Jefferson
Medical College. She
plans to continue with
Internal Medicine and
is interested in the
Hospitalist track. She serves on the
Jefferson Doctor-Nurse Communication
Committee and Women’s Health
Subcommittee and volunteers with Jeff
HOPE, a student-run health program 
for Philadelphia’s homeless. She and her 
husband, also a physician, are new parents
of twin girls. ■
Dr. McCullen
For Chief Residents It’s All in a Day’s Work
Dr. Rose
Dr. Kipnes
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Frederic Jaffe, DO, and a technician review a
study in the Sleep Disorders Center control room.
Pulmonary and Critical Care
The Center staff also strives to educate
medical students and other physicians
about the pervasiveness and intricacies of
sleep disorders. “Unfortunately, patients
and their physicians rarely discuss sleep
habits during routine office visits or even
while patients are in the hospital,” Dr.
Jaffe says. “Although sleep science has
advanced greatly over the last century,
Education
Continued on page 7
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The Department of Medicine is grateful 
to all of our donors for their generous 
support of our centers, faculty, research, 
and education in the past year. 
Charitable gifts support the amazing work
our physicians do every day and help the
department to continue to expand its
legacy as a leader in the region. This help
makes it possible for us to recruit the finest
physicians and residents, educate the 
most talented students, and advance our 
longstanding tradition of translating our
patients’ problems today into the next
generation of medical care. Thank You!
To learn more about giving opportunities
within the Department of Medicine, 
please contact Margaret Fala, Director of
Development, Department of Medicine at
The Jefferson Foundation, at 215-955-7556
or margaret.fala@jefferson.edu.
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Five new faculty have joined the Division
of Internal Medicine: Donna Williams,
MD; Jennifer Cowan, MD; Albert Lee,
MD; Taki Galanis, MD; and Nathan
Negin, MD.
The Division of Nephrology welcomes
Won Kook Han, MD, Yonghong L.
Huan, MD, and JuFang Wang, PhD.
New Faculty
The Department of Medicine is pleased to
announce that Barry S. Ziring, MD, has
been named the Director of the Division 
of Internal Medicine, and Oscar Irigoyen,
MD, has been named the Acting Director
of the Division of Rheumatology.
The Division of Cardiology has two new
faculty: Ira Cohen, MD, and Daniel
Frisch, MD.
Glenn Radice, PhD, has joined the Center
for Translational Medicine.
Wolfgang Bergmeier, PhD, and Saleh
Ayache, MD, have joined the Division 
of Hematology.
The Division of Infectious Diseases 
welcomes Dionissios Neofytos, MD.
Faculty News
The Division of Endocrinology invites 
you to visit the Jefferson Weight
Management Program’s new website at 
www.jefferson.edu/endocrinology/
weightmanagement and learn more
about our highly successful options 
for losing weight and keeping it off. 
Awards and Honors
Thomas Force, MD, the James C.
Wilson Professor of Medicine and
Clinical Director of the Center for
Translational Medicine, received the
“Albrecht Fleckenstein Memorial
Award” for distinguished contribution
to basic research. Members of the
Faculty of the International Academy
of Cardiology — a world-renowned
panel of 140 cardiologists and 
scientists — announced the award
during the 13th World Congress on
Heart Disease held in Vancouver in 
July 2007.
In September 2007, Nature
Medicine published a paper 
by Hui Zhang, MD, PhD, Associate
Professor, Division of Infectious
Diseases and Environmental Medicine,
and his colleagues, suggesting that
cellular microRNAs can help HIV 
persist by shutting off viral replication
and contributing to latency. To view
the article online visit www.
nature.com/nm/index.html.
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